Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	28.73	43.63	33.89
Graham Fair Price	4.85	27.69	26.41
PEG	249.16	-2.37	0.68
Price/Book	-9.92	5.50	6.11
Price/Cash Flow	75.57	-10.50	5.98
Prices/Earnings	12.99	15.02	13.29
Price/Sales	15.76	1.18	1.02
Price/FCF	75.57	-10.50	5.98
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	43.77	0.07	0.05
Operating Margin	12.57	0.02	0.02
ROA	-4.52	< 0.005	< 0.005
ROE	0.11	0.09	-20.27
ROIC	0.02	0.01	-24.25
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	0.10	11.08	-99.14
Dividends QOQ	0.00	-1.00	-100.00
EBIT QOQ	-0.43	0.03	-93.37
EPS QOQ	0.20	-0.06	-67.64
FCF QOQ	57.67	-1.60	-97.22
Revenue QOQ	< 0.005	-0.09	1225.20
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	4.74	5.68	19.62
Days Sales Outstanding (DSO)	80.29	103.67	29.11
Inventory Turnover	18.97	15.86	-16.40
Debt/Capitalization	0.81	0.80	-1.22
Quick Ratio	1.03	1.17	13.05
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	16.43	19.29	17.43
Cash	76.80	68.06	-11.39
Capex	-0.55	-0.51	7.99
Free Cash Flow	16.77	-10.11	-39.75
Revenue	98.31	89.84	-8.62
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.11	1.20	8.03
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.51	7.35	387.86
Naive Interpretation	Member

06 - Financial Health · Weak

Rating